Meaningful Activities: Podcast with Anna Oh and Theresa Allison
October 28, 2021
Most studies in geriatrics have used metrics such as survival time or disability in activities of daily living as their…
Most studies in geriatrics have used metrics such as survival time or disability in activities of daily living as their…
The FDA label for the amyloid antibody aducanumab (Aduhelm) started off exceedingly broad, basically including anyone with Alzheimer’s disease, but…
“The take home message of this study is NOT that primary palliative care does not work.” So says Yael Schenker of…
Time-limited trials. We’ve all probably used them before. We meet with patients and families. We agree to either start or…